PRIME
advanced and versatile PRInting platform for the
next generation of active Microfluidic dEvices
PRIME has received funding from the European Union`s Horizon 2020 Research & Innovation Programme under grant agreement no 829010.
About the Project
Microfluidic devices manipulate tiny amounts of fluid enabling cost-effective, fast, accurate and high throughput analytical assays. Progress in Microfluidics has huge impact in environmental pollution monitoring, biohazard detection and biomedicine, contributing to the development of new tools for drug screening, biological studies, point-of-care diagnostics and personalized medicine.
Objectives
PRIME aims to go beyond the state-of-the-art generating a robust platform to create a new generation of active, tubeless and contactless microfluidic chips effectively changing the currently established paradigm.
Beneficiaries
Six organisations from Spain, the Netherlands, Germany and Austria participate at the PRIME project.